Company: ARVN
Filing Date: 2025-12-08
Form Type: 8-K
Source: 0001628280-25-055682
Chunk: 3

Company: ARVINAS, INC.
Filing Date: 2025-12-08
Form: 8-K
Item: Item 9.01
Chunk 3
---
Item 9.01 Financial Statements and Exhibits.

  Exhibit Number      Description of Exhibit                                       
 ───────────────────────────────────────────────────────────────────────────────────
            99.1      Press Release, dated Dece mber 6, 2025                       
             104      Cover Page Interactive Data File (formatted as Inline XBRL)  

Forward-Looking Statements

This Current Report on Form 8-K contains forward-looking statements that involve substantial risks and uncertainties, including statements regarding the plans for ARV-393 and the timing of any clinical trial initiation or data presentation. All statements, other than statements of historical facts, contained in this Current Report on Form 8-K, including statements regarding the Company’s belief in the potential of its product candidates, strategy, future operations, prospects, plans and objectives of management, are forward-looking statements. The words "believe," "intends," "plans," "potential,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements

contain these identifying words. The Company may not actually achieve the plans, intentions or expectations disclosed in its forward-looking statements, and you should not place undue reliance on such forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements the Company makes as a result of various risks and uncertainties, including the important factors discussed the important factors discussed in the “ Risk Factors” sections contained in the Company’s quarterly and annual reports on file with the U. S. Securities and Exchange Commission. The forward-looking statements contained in this Current Report on Form 8-K reflect the Company’s current views with respect to future events, and the Company assumes no obligation to update any forward-looking statements except as required by applicable law. These forward-looking statements should not be relied upon as representing the Company’s views as of any date subsequent to the date of this Current Report on Form 8-K.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

                              ARVINAS, INC.                               
  Date: December 8, 2025      By:                /s/ Andrew Saik          
                                                 Andrew Saik